April 17, 2025

Medical Oddities: Cells Are Listening?

Cytokines, cigarettes, and COX-2—this week’s studies are nothing if not eclectic.

Conexiant

April 17, 2025

Eyebrows Signal Understanding Gaps in Conversation

Eyebrow furrows can silently signal 'I've not received enough information.'

Conexiant

April 17, 2025

We Want Your Perspective!

Join our roster of respected specialists and share your clinical perspectives.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 14, 2025

Inebilizumab Effective for Myasthenia Gravis

CD19+ B-cell-depleting therapy shows significant improvement in function and disease severity in phase III trial of autoimmune neuromuscular disorder.

Conexiant

April 14, 2025

Semaglutide Users Face Increased Gastroparesis Risk

Study reveals semaglutide users face significantly higher gastroparesis risk compared to bupropion-naltrexone and sleeve gastrectomy, highlighting the need for careful treatment consideration.

Conexiant

April 11, 2025

New Self-Injection Option for gMG, CIDP

A prefilled syringe version of VYVGART Hytrulo, which enables adult patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy to self-administer treatment in as little as 20 to 30 seconds, has been approved by the FDA.

Conexiant

April 10, 2025

Microplastics Linked to Brain Disability Spike

Higher rates of cognitive, mobility, and self-care disabilities found in coastal counties with elevated marine microplastic levels.

Conexiant

April 08, 2025

Distressing Dreams Tied to Early Death, Study

Adults with frequent nightmares face nearly triple the risk of premature mortality.

Conexiant